<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1AD37A82-0DC3-4A84-893C-F32A7B4EB56F"><gtr:id>1AD37A82-0DC3-4A84-893C-F32A7B4EB56F</gtr:id><gtr:name>French National Institute of Agricultural Research (INRA)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1AD37A82-0DC3-4A84-893C-F32A7B4EB56F"><gtr:id>1AD37A82-0DC3-4A84-893C-F32A7B4EB56F</gtr:id><gtr:name>French National Institute of Agricultural Research (INRA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0284DA29-975E-4918-B2D3-2F81CDEC3394"><gtr:id>0284DA29-975E-4918-B2D3-2F81CDEC3394</gtr:id><gtr:firstName>Florian</gtr:firstName><gtr:surname>Hollfelder</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0300193"><gtr:id>07E3B88B-A5C4-4C1D-A1C8-7EE89D5AD663</gtr:id><gtr:title>Directed Evolution Approaches to Manipulation of Biological Pathways</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300193</gtr:grantReference><gtr:abstractText>The motivation behind this proposal is best summarised in the words of Thomas Alva Edison: Until man reproduces a blade of grass Nature will laugh at our so-called scientific knowledge. This proposal is part of a long-term effort aimed at reproducing Nature s remarkable ability to generate molecular machines that perform at levels near perfection. Most biological processes involve the action of enzymes, which are central for explaining the workings of living cells and organisms. However, there is no comprehensive quantitative understanding of enzyme action and our current understanding certainly fails the most severe test ? that of producing catalysts with rates that rival natural enzymes. We want to address this complex question by evolution experiments in the test tube, harnessing the forces of Darwinian evolution. The evolutionary snapshots should then tell us how a catalytic machineries involved in signalling cascades and the biosyntheis of un-natural natural products (as potential drug candidates) are built up ? and generate useful reagents that may make it possible to probe signaling pathways and make new potential drug candidates.</gtr:abstractText><gtr:technicalSummary>By mechanistic understanding of biological processes starting at tthe basic level of mechanistic organic chemistry in enzyme active sites, i plan to work towards a knowledge base fro understanding the molecular basis of diseases, to probe and manipulate cellular processes, to generate natural products with new and altered properties or to produce environmentally friendly, high-quality reagents for application in synthetic chemistry and biotechnology. To this end I use a new in vitro evolution technology (GENESCIS) that allows multiple rounds of selection from libraries of 10e10 memebers directly for catalysis. Evolution of new activities is based on mechanistic ratinoales and identified catalytic solutions will provide snapshots of the evolution of mechanism.
In a first sub-project I focus on the enzymology of phosphokinase catalysis. This type of reaction is crucial for signal transduction pathways that can lead e.g. to reprogramming of the cell cycle and ultimately to cancer. By in vitro evolution, I want to achieve altered specificity, gradual increases of activity (for mutants with broadened specificity), and activity switches to the related sulfokinase reaction (based on transition state similarity and the observation of catalytic promiscuity. These mutant enzymes could then be tested for their physiological roles e.g. in signal transduction and provide tools to pin-point the roles of sulfate and phosphate transfer enzymes in the cellular machinery. In a second subproject (2.2) I plan to use in vitro evolution to understand and engineer multifunctional enzymes that operate as molecular assembly lines in non-ribosomal peptide biosynthesis, in particular gramicidin synthetase. Our general objective is to expand the scope of such natural system of combinatorial chemistry by directed evolution. Many peptide-based natural products of therapeutic importance are synthesised by nonribosomal peptide synthetases (NRPSs), such as the immunosuppressants cyclosporine, the ?antibiotic of last resort? vancomycin and part-structures of the anti-cancer agent epothilone or the beta-lactam antibiotics. Our proposal aims at mixing and matching enzyme modules to allow the generation of novel compounds - natural products and new, non-natural analogs that are inaccessible straightforwardly by synthetic chemistry. We believe that altering and swapping modules could give rise to novel protein templates that can be used to assemble and produce expanded repertoires of natural-product-like compounds of rich therapeutical potential.</gtr:technicalSummary><gtr:fund><gtr:end>2010-01-20</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-07-21</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>418946</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>French National Institute of Agricultural Research (INRA)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Sulfatases</gtr:description><gtr:id>7A7AA9AD-64F4-4DE9-B034-7C053E9D171A</gtr:id><gtr:impact>See our PNAS paper (van Loo et al, 2010) in list of publications.</gtr:impact><gtr:partnerContribution>Knowledge about modification of active site Cys to fGly.</gtr:partnerContribution><gtr:piContribution>Protein expression, structural and functional characterisation and kinetic analysis (95%).</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BBC Radio The Naked Scientist</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8676D157-4022-4A34-BE8D-05D251F803AA</gtr:id><gtr:impact>Radio Interview on my research activities.

Audience feedback.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ELRIG Drug Discovery Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6BDE8022-FBD7-479F-88A4-4121F36715FF</gtr:id><gtr:impact>Presentation to industrial audience.

Industrial funding and collaboration.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU Marie-Curie ITN:European Network on Evolution of FUnctional Proteins</gtr:description><gtr:fundingOrg>Marie Curie Actions</gtr:fundingOrg><gtr:id>6683C854-0BFD-4B3E-9F45-4A4046403BDB</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0AAD42CB-0AF6-4574-8BE4-36E0CDACAB3E"><gtr:id>0AAD42CB-0AF6-4574-8BE4-36E0CDACAB3E</gtr:id><gtr:title>Directed evolution of a gatekeeper domain in nonribosomal peptide synthesis.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a7f74275f06c96a864eb1d1b9ebd077"><gtr:id>3a7f74275f06c96a864eb1d1b9ebd077</gtr:id><gtr:otherNames>Villiers B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF405BCB-BFBE-4A4E-8639-85DF4C098807"><gtr:id>DF405BCB-BFBE-4A4E-8639-85DF4C098807</gtr:id><gtr:title>An efficient, multiply promiscuous hydrolase in the alkaline phosphatase superfamily.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/217131ede904ded25c4687dc81602d03"><gtr:id>217131ede904ded25c4687dc81602d03</gtr:id><gtr:otherNames>van Loo B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7FD045B2-CB6C-41E7-A60B-D5B320311EB4"><gtr:id>7FD045B2-CB6C-41E7-A60B-D5B320311EB4</gtr:id><gtr:title>Efficient catalytic promiscuity in an enzyme superfamily: an arylsulfatase shows a rate acceleration of 10(13) for phosphate monoester hydrolysis.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/99cc36592818b87806975e5b7a969549"><gtr:id>99cc36592818b87806975e5b7a969549</gtr:id><gtr:otherNames>Olguin LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2BE22EB8-C769-4AF4-B91B-DC602CE236BE"><gtr:id>2BE22EB8-C769-4AF4-B91B-DC602CE236BE</gtr:id><gtr:title>USER friendly DNA recombination (USERec): gene library construction requiring minimal sequence homology.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a7f74275f06c96a864eb1d1b9ebd077"><gtr:id>3a7f74275f06c96a864eb1d1b9ebd077</gtr:id><gtr:otherNames>Villiers B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C9CB29BC-62DA-4CE0-9BF8-96C443FCE7FB"><gtr:id>C9CB29BC-62DA-4CE0-9BF8-96C443FCE7FB</gtr:id><gtr:title>USER friendly DNA recombination (USERec): gene library construction requiring minimal sequence homology.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a7f74275f06c96a864eb1d1b9ebd077"><gtr:id>3a7f74275f06c96a864eb1d1b9ebd077</gtr:id><gtr:otherNames>Villiers B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/569FD1A0-817C-4F46-9C2B-1B9FA1485195"><gtr:id>569FD1A0-817C-4F46-9C2B-1B9FA1485195</gtr:id><gtr:title>USER friendly DNA recombination (USERec): a simple and flexible near homology-independent method for gene library construction.</gtr:title><gtr:parentPublicationTitle>Protein engineering, design &amp; selection : PEDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/520256a9647887c844ebc4213cca7b77"><gtr:id>520256a9647887c844ebc4213cca7b77</gtr:id><gtr:otherNames>Villiers BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1741-0126</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8A1CC0F-275B-4F19-80AB-AF46F708EDAA"><gtr:id>E8A1CC0F-275B-4F19-80AB-AF46F708EDAA</gtr:id><gtr:title>Mapping the limits of substrate specificity of the adenylation domain of TycA.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/520256a9647887c844ebc4213cca7b77"><gtr:id>520256a9647887c844ebc4213cca7b77</gtr:id><gtr:otherNames>Villiers BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300193</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8EA3EC93-8E9C-482F-8121-C6C8413D9B6D</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.3  Chemical and physical sciences</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>